Ground-Breaking SIRIUS Endoscope System Is Leading the Next Minimally Invasive Surgical Revolution
Precision Robotics Hong Kong Home of Next Generation Surgical Robots HONG KONG, Nov. 8, 2022 /PRNewswire/ -- Founded in 2017 and based in Hong Kong Science Park, an innovative robotic start-up company, Precision Robotics (Hong Kong) Limited (PRHK), has entered a significant milestone with its revolutionary flagship product—SIRIUS Endoscope System. The SIRIUS system is a fully integrated 3D HD compact camera system with...
BIORCHESTRA announces that BMD-001 reduces Amyloid-β and Tau in non-human primate animal model of Alzheimer’s Disease at the RNA Leaders USA Conference in Boston
BOSTON, Nov. 8, 2022 /PRNewswire/ -- Dr. Branden Ryu, CEO and Founder of BIORCHESTRA Ltd. (S. Korea), was a featured speaker at a plenary session of the RNA Leaders Congress USA in Boston, MA, on October 18th, 2022. Dr Ryu focused on the new efficacy data of their leading compound, BMD-001, derived from studies in non-human primates that demonstrated...
Update on overseas clinical trials progress of novel adjuvant COVID-19 vaccine ReCOV
TAIZHOU, China, Nov. 8, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that positive results were achieved for its primary vaccination Phase II study in the Philippines and heterologous booster vaccination Phase II study in United Arab Emirates ("UAE") in...
111 to Announce Third Quarter 2022 Unaudited Financial Results on December 1, 2022 – Conference Call to Follow
SHANGHAI, Nov. 8, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2022, before the U.S. market opens on Thursday, December...
World One Health Congress commences in Singapore
Focusing on the imperative of integrating science, policy and clinical practice to advance global One Health movement especially in the aftermath of COVID-19, the Congress will feature sharing by leading global scientists and policymakers on ways to address complex global health challenges. SINGAPORE, Nov. 8, 2022 /PRNewswire/ -- The 7th World One Health Congress (WOHC), the world's premier event to advance the One Health...
1 in 2 diabetics suffer from Peripheral Neuropathy[1] during their lifetime
P&G Health, makers of Neurobion, embark on an effort to help people 'Put Life Back in Their Hands' for an improved quality of life. Launched on World Diabetes Day across 18 countries, the campaign raises awareness on Peripheral Neuropathy in diabetes, and the importance of early identification and timely treatment. SINGAPORE, Nov. 8, 2022 /PRNewswire/...
Osteopore’s Breakthrough Natural Tissue Regeneration Technology Leaps into Global Spotlight
The global leader's innovative regenerative medical technology and devices vastly improve patient outcomes and reduce overall medical costs. SINGAPORE, Nov. 8, 2022 /PRNewswire/ -- Osteopore International (ASX:OSX) ("Osteopore", "OSX" or the "Company"), a Singapore- and Australia-based med-tech company focusing on facilitating natural tissue regeneration, is primed for the global limelight after quietly developing and commercialising its novel 3D-printed bioresorbable scaffold...
DocDoc to work with Aon and insurers in Asia to offer data-enabled patient empowerment solutions to members of employer health plans
This collaboration will address a growing need among employers for effective cost-containment solutions, which empower their members with the data they need to make impactful healthcare decisions. DocDoc's data-enabled group health insurance solutions are to be offered to Aon's clients across multiple markets in Asia starting with Singapore in October 2022, followed by other markets in the region, in...
Cyagen and Neurophth Enter Global Strategic Collaboration to Develop AI-Designed AAV Gene Therapy Vectors for Ophthalmic Disorders
SANTA CLARA, Calif., Nov. 8, 2022 /PRNewswire/ -- Cyagen today announced a strategic collaboration with Neurophth Therapeutics, Inc. to co-develop next-generation AAV gene therapy vectors for specific types of genetic ophthalmic disorders. Under the terms of the agreement, Cyagen will apply its proprietary artificial intelligence (AI)-powered high-throughput platform to discover novel AAV vectors with optimized tissue targeting...
Sirnaomics Doses the First Patient in Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Aesthetics Treatment
Data results expected to be available in 1H 2023 GAITHERSBURG, Md. and SUZHOU, China, Nov. 8, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today the Company has dosed the first patient in a Phase I clinical study of STP705, a siRNA (small...
